Epic will provide its diagnostic enterprise suite for laboratories to support Quest’s multi-year Project Nova programme.

SECAUCUS, N.J., Sept. 23, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Epic today announced a first-of-its-kind collaboration designed to streamline and improve experiences for healthcare ...

Quest Diagnostics partners with Hackensack Meridian’s School of Medicine, giving students hands-on lab training at its ...

Quest Diagnostics (DGX) and Epic announced a first-of-its-kind collaboration designed to streamline and improve experiences for healthcare ...

Guardant Health and Quest Diagnostics will collaborate to offer Guardant’s Shield blood-based colorectal cancer test through ...

Narrow-moat Quest Diagnostics delivered second-quarter results that slightly exceeded our expectations on the top line, but that was offset by earnings that fell slightly short of our full-year ...

The number of transplantation operations, both for solid organs and stem cells, has increased steadily for over a decade. Every transplantation requires comprehensive testing of both donor and ...

Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that detects and measures the level of per- and polyfluorinated alkyl substances (PFAS), a potentially harmful ...